Topic Archives: ProMIS Neurosciences (PMN.TO ARFXF)

I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]

“This Wednesday, September 5 Tuesday, May 28, a group of scientists will take the stage at a prestigious medical conferenceā€¦ “And announce to the world the potential end of disease as we know it.” That’s the attention-getting part of Ray Blanco’s latest teaser ad for his FDA Trader newsletter that Gumshoe readers have been asking […]

Ray Blanco makes (part of) his living looking for biotech moonshots, like most biotech-focused newsletter writers — and like his predecessor at Agora’s biotech and emerging tech-focused newsletter Breakthrough Technology Alert, he has often touted companies that are trying to end the scourge of Alzheimer’s Disease. Why? Well, two main reasons: First, and by far […]

Comments

  • Travis Johnson, Stock Gumshoe

    I haven't looked at anything new from Hodge on this, but covered a very similar tease a little over a year ago that was ...

  • Avatar

    As pointed out Electricity Cost of running Computers plus Cooling Cost drain on gains of Bitcoin mining. Does anyone...

  • Avatar

    Comment submitted, not sure received!!...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info